ArticlePediatric emergency care2025
Disparities in Pediatric Emergency Department Revisits Within 7 Days by Disease Process.
Article in Pediatric emergency care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo identify disease processes in which patients experienced the greatest rates of emergency department (ED) revisit disparities by race, ethnicity, language, insurance, and Childhood Opportunity Index.
methodsWe performed a retrospective, cross-sectional study of ED visits at a comprehensive pediatric health system encompassing three EDs. We included all pediatric (0 to 18 y) ED encounters that led to a discharge home (2018 to 2022). The primary outcome was ED revisit within 7 days of the index encounter. We performed multivariable logistic regression to assess the relationship between diagnoses, patient demographics, and 7-day ED revisit.
resultsThere were 1,008,651 total ED encounters included [53% (n = 529,960) were male]. Of all encounters, 52,176 (5.2%) had a 7-day ED revisit within the system. Patients who identified as black/African American (adjusted odds ratio [aOR]: 1.14, 95% CI: 1.11-1.17), multiracial (aOR: 1.14, 95% CI: 1.06-1.22), Hispanic (aOR: 1.21, 95% CI: 1.17-1.26), and those with public insurance (aOR: 1.19, 95% CI: 1.16-1.23) had greater odds of ED revisit. Disparities in ED revisits among Hispanic patients were concentrated in a few high-volume diagnoses, particularly within ear, nose, throat (ENT)/dental/mouth diseases (aOR: 1.11, 95% CI: 1.01-1.21) such as upper respiratory infections and infectious ear diseases. Conversely, disparities in ED revisits for black/African American patients were widespread across a broader range of diagnoses.
conclusionsDisease-focused interventions are needed to reduce disparities in ED return visits. Focusing on upstream determinants of health may better reduce the burden of ED revisits for minoritized populations at risk of ED revisits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.